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Cytokinesis controls the proper segregation of nuclear and cytoplasmic
materials at the end of cell division. The chromosomal passenger complex
(CPC) has been proposed to monitor the final separation of the two daughter
cells at the end of cytokinesis in order to prevent cell abscission in the presence
of DNA at the cleavage site, but the precise molecular basis for this is unclear.
Recent studies indicate that abscission could be mediated by the assembly of
filaments comprising components of the endosomal sorting complex required
for transport-III (ESCRT-III). Here, we show that the CPC subunit Borealin
interacts directly with the Snf7 components of ESCRT-III in both Drosophila
and human cells. Moreover, we find that the CPC’s catalytic subunit, Aurora
B kinase, phosphorylates one of the three human Snf7 paralogues—
CHMP4C—in its C-terminal tail, a region known to regulate its ability to
form polymers and associate with membranes. Phosphorylation at these sites
appears essential for CHMP4C function because their mutation leads to cyto-
kinesis defects. We propose that CPC controls abscission timing through
inhibition of ESCRT-III Snf7 polymerization and membrane association using
two concurrent mechanisms: interaction of its Borealin component with Snf7
proteins and phosphorylation of CHMP4C by Aurora B.2. Introduction
Cytokinesis, the final separation of two daughter cells at the end of cell division,
requires the coordinated action of several proteins that promote the formation
and ingression of a cleavage furrow that bisects the dividing cell. Many key
cytokinesis proteins localize to an array of anti-parallel and interdigitating
microtubules known as the central spindle, which forms between the segregat-
ing anaphase chromosomes during furrow ingression [1]. The central spindle
and its associated proteins control furrow formation and ingression, the trans-
port of membrane vesicles to the cleavage site and the final abscission of the
two daughter cells [2–4]. In the final stages of cytokinesis, the central spindle
Table 1. List of ESCRT-III components in different organisms.
Saccharomyces cerevisiae Drosophila Homo sapiens
Vps2/Did4 CG4618 CHMP2A, B
Vps20 Vps20 CHMP6
Vps24 CG9779 CHMP3
Vps32/Snf7 Shrb CHMP4A, B, C
Vps46 Chmp1 CHMP1A, B
Vps60 CG6259 CHMP5
none CG5498 CHMP7
Table 2. Summary of mass spectrometry results from the affinity
purifications of PtA-tagged Borr and Shrb. Some of the proteins
identified from the affinity purifications are listed along with their relative
Mascot score and number of peptides. Deterin is the Drosophila orthologue
of Survivin.
Bait interactors score peptides
Borr::PtA Shrb (Snf7) 1099 32
INCENP 1085 43
Aurora B 588 26
Deterin (Survivin) 406 18
PtA::Borr Shrb (Snf7) 1125 31
INCENP 714 34
Aurora B 200 10
Deterin (Survivin) 333 10
PtA::Shrb Aurora B 264 10
INCENP 236 7
Deterin (Survivin) 204 3
Borr 48 2
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forms a compacted structure known as the midbody, which
contains at its centre a phase-dense structure—the midbody
ring or Flemming body—important for cell abscission. Our
knowledge of the mechanisms that control furrow formation
and ingression has advanced considerably in the last few
years [5]. However, the mechanics and regulation of abscission
are still unclear. Recent studies indicate that the endosomal
sorting complexes required for transport (ESCRTs) play a
key role during cell abscission [6–11]. These evolutionarily
conserved complexes are best known for catalysing the sorting
of receptors at endosomal membranes into vesicles that bud
off into the lumen of the endosome, creating the multivesicu-
lar bodies (MVBs) [12]. The cargo of MVBs is then routed
into lysosomes for degradation. Four distinct ESCRTs—
known as ESCRT-0, -I, -II and -III—are sequentially recruited
to endosomes through both protein and lipid interactions
[12]. ESCRT-III, the final complex in the pathway, provides
the core machinery that mediates membrane deformation
and fission events during MVB biogenesis [13]. This complex
comprises 11 subunits in humans (also known as charged mul-
tivesicular body proteins, CHMPs), which correspond to six
counterpart proteins in yeast and seven in Drosophila (table 1)
[14]. ESCRT proteins have also been implicated in other mem-
brane-budding processes, including retroviral budding and,
importantly, cytokinesis that are topologically similar to the
budding required for MVB formation [12,14,15]. ESCRT-I
and -III components have been found to localize to the mid-
body, and ESCRT-III components have been proposed to
mediate membrane fission at the end of cytokinesis [6–11].
The spatial and temporal signals that control abscission in
metazoans are poorly understood. One signalling component
that has been implicated in these late stages of cytokinesis is
the chromosomal passenger complex (CPC). This evolutiona-
rily conserved complex comprises four components: the inner
centromeric protein (INCENP), the Aurora B serine/threo-
nine kinase, Survivin and Borealin [16,17]. CPC is essential
for multiple processes during cell division, including con-
densation of chromosomes, their alignment and proper
attachment to spindle microtubules, and cytokinesis [17].
Consistent with these functions, the CPC follows a dynamic
distribution during mitosis: it localizes to centromeres at
mitotic entry, translocates to the central spindle and cleavage
furrow after anaphase onset and concentrates at the midbody
in late telophase [16]. Studies in many organisms have
revealed that CPC components are crucial for completion of
cytokinesis [17] and evidence in both yeast and mammals
have indicated that Aurora B activity is necessary to prevent
cell abscission in the presence of chromosome bridges at the
cleavage site, functioning as a ‘NoCut’ checkpoint [18–20].Here, we show that Borealin interacts directly with Snf7/
Shrb/CHMP4 components in both Drosophila and human cells
and that the two proteins colocalize at the midbody in late cyto-
kinesis. Moreover, we found that Aurora B phosphorylates
CHMP4C at three serine residues located in its C-terminal
linker region, a part of the protein known to regulate its ability
to form polymers and interact with the membrane. Finally,
over-expression of CHMP4C variants mutated in these three resi-
dues caused cytokinesis failure, suggesting that Aurora B inhibits
CHMP4C activity during cytokinesis. We propose that CPC con-
trols abscission timing in both flies and human cells by regulating
the function of ESCRT-III Snf7 proteins during cytokinesis
through the interaction of its Borealin component with the
N-terminus of Shrb/CHMP4 proteins and Aurora B-mediated
phosphorylation of the CHMP4C regulatory linker tail.3. Results
3.1. Borealin-related protein interacts with the ESCRT-III
Shrb component in Drosophila cells
In a proteomic survey of complexes involved in cell division in
Drosophila, we tagged the CPC Borealin-related (Borr) com-
ponent with two IgG-binding domains of Protein A (PtA) at
either its N- or C-terminus. The presence of a tag at either
end of Borr did not affect the localization of the protein (see
electronic supplementary material, figure S1, and data not
shown). Independent Drosophila cell lines stably expressing
PtA-tagged Borr proteins were generated, and interacting part-
ners isolated by affinity purification and identified by mass
spectrometry (MS). In both purifications, we identified the
ESCRT-III component Shrb with a score comparable to or
even higher than INCENP (table 2). A reciprocal affinity puri-
fication using cells expressing PtA::Shrb also identified all the
CPC components (table 2), confirming the association in vivo.
Because Borr and INCENP interact directly, these MS data
suggested that Borr could also bind to Shrb directly.
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Figure 1. Borr interacts and colocalizes with the ESCRT-III component Shrb in Drosophila cells. (a) The GST::Borr fragments indicated on the schematic in the upper
part were purified from bacteria and incubated with Shrb translated and radio-labelled in vitro, and then pulled down using glutathione beads. The Ponceau S
staining of the protein loading is shown in the lower part. The numbers on the left indicate the sizes (kDa) of the molecular mass marker. On the right is shown a
schematic of the positive (þ) and negative (2) results of the GST pull down. (b) GST::Aurora B (AurB) was purified from bacteria and incubated with Shrb
translated and radio-labelled in vitro, and then pulled down using glutathione beads. The Ponceau S staining of the protein loading is shown at the bottom. The
numbers on the left indicate the sizes (kDa) of the molecular mass marker. (c) Drosophila S2 cells stably expressing Shrb::GFP were fixed and stained to detect
Aurora B (red in the merged panel), GFP (green in the merged panel) and DNA (blue in the merged panel). Midbody presence and DNA condensation were used as
criteria to stage cells during cytokinesis. The inset shows a 2 magnification of the midbody. Scale bar, 10 mm.
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To confirm this, we used an in vitro glutathione S-transferase
(GST) pull-down assay (figure 1a). We generated several
GST-tagged Borr fragments in bacteria and tested their ability
to pull down a radio-labelled Shrb polypeptide synthesized by
in vitro translation (figure 1a). Full-length Borr1 – 315 and the
truncated Borr1 –249 fragment pulled down Shrb very effi-
ciently, whereas Borr1 –117 did not (figure 1a). Borr118–315
could also efficiently pull down Shrb, whereas both Borr118 –
249 and the most C-terminal Borr250– 315 fragment did not
bind to Shrb (figure 1a). We conclude that the Borr118–249 cen-
tral region is necessary, but not sufficient, for the interaction
with Shrb. No direct interaction was observed with two other
components of the CPC, INCENP (data not shown) and
Aurora B (figure 1b), using a similar assay. To assess if and
when CPC colocalized with Shrb during mitosis, we generated
a stable cell line stably expressing Shrb tagged with green flu-
orescent protein (GFP). In late telophase, both Shrb::GFP and
Aurora B accumulated at the midbody where the two proteins
partially colocalized (figure 1c). However, Shrb::GFP appeared
to localize to the midbody ring, whereas Aurora B was more
broadly distributed. Finally, during abscission, only Shrb was
visible at the midbody (figure 1c). Altogether, these results
indicate that Shrb and Borealin interact in late cytokinesis just
before abscission.3.2. Borealin interacts with ESCRT-III CHMP4 proteins
in human cells
We then investigated whether the interaction between Borea-
lin and ESCRT-III Snf7 components had been conserved inhuman cells. There are three Snf7 paralogues in humans:
CHMP4A, CHMP4B and CHMP4C (table 1). The primary
sequence of the three CHMP4 proteins and their Drosophila
homologue Shrb is very well conserved, although all four
proteins diverge considerably in their C-terminal regions
(figure 2). To assess whether Borealin could interact with
CHMP4 proteins in vivo, we transfected HeLa cells with
either PtA-tagged Borealin or PtA alone as control, and
each of the three CHMP4 proteins tagged with GFP. PtA::Bor-
ealin pulled down GFP::CHMP4A and GFP::CHMP4B very
efficiently, but not GFP::CHMP4C or GFP alone (figure 3a).
To investigate whether these interactions were direct, we car-
ried out an in vitro GST pull-down assay as described earlier
for Borr and Shrb. GST-tagged Borealin purified from bac-
teria could efficiently pull down all three CHMP4 proteins
synthesized by in vitro translation (figure 3b). Our inability
to detect an interaction between Borealin and CHMP4C in
vivo, in contrast with the positive outcome of the in vitro
assay, suggests that the interaction might be regulated by
post-translation modifications and/or may occur only in a
specific phase of the cell cycle and therefore, not be easily
detectable in our unsynchronized cell populations.
To identify the Borealin domain responsible for the inter-
action with CHMP4 proteins, we tested the ability of different
GST–Borealin fragments to pull down one of the three
CHMP4 paralogues. Although all three CHMP4 proteins
could strongly bind to Borealin in vitro, CHMP4C appeared
to interact slightly more efficiently (figure 3b) and thus we
decided to use this paralogue for the next pull-down
assays. Borealin contains an N-terminal region (amino acid
1–109) that interacts with INCENP, and a C-terminal
CHMP4A/1–222
CHMP4B/1–224
CHMP4C/1–233
Shrb/1–226
CHMP4A/1–222
CHMP4B/1–224
CHMP4C/1–233
Shrb/1-226
conservation
conservation
CHMP4A/1–222
CHMP4B/1–224
CHMP4C/1–233
Shrb/1–226
conservation
Figure 2. Human and Drosophila ESCRT-III Snf7 proteins are very well conserved except in their C-terminal tails. CHMP4A, CHMP4B, CHMP4C and Shrb sequences
were aligned using the BLAST program (http://www.ncbi.nlm.nih.gov/) and the Blosum62 colouring scheme (matches are highlighted in dark blue, and positive
alignment scores in light blue). The conservation histogram (yellow and brown bars) is shown below. Conservation is measured as a numerical index reflecting the
conservation of physico-chemical properties in the alignment: identities (indicated by asterisks) score highest and the next most-conserved group contains
substitutions to amino acids lying in the same physico-chemical class. The serine residues phosphorylated by Aurora B are boxed in red.
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region (amino acid 208–280) required for dimerization
(figure 3c) [21,22]. We found that the Borealin central
region encompassing residues 110–207 was both necessary
and sufficient to bind to CHMP4C (figure 3c). However,
the interaction was lost if the fragment also contained the
dimerization domain (figure 3c). We conclude that Borealin
interacts with CHMP4 proteins via its central region, similar
to its Drosophila counterpart Borr, but for reasons that are not
clear the dimerization domain seems to interfere with the
binding ability of the isolated central region but not of the
full-length protein (figure 3c).
To pinpoint the CHMP4C domain able to bind to Borea-
lin, we tested whether the N- and C-terminal halves of the
protein were able to pull down radio-labelled Borealin syn-
thesized by in vitro translation (figure 3d ). These two
regions are quite different in their structure and charge. The
N-terminal half (amino acid 1–121) is basic and contains
two alpha-helices (a12), whereas the C-terminal half (amino
acid 122–233) is acidic and contains three alpha-helices
(a345; figure 3d ). We found that GST::CHMP4C1 – 121 could
bind to Borealin very efficiently, even better than the full-
length protein, whereas GST::CHMP4C122 – 233 could only
weakly pull down Borealin to a level similar to that of GST
alone (figure 3d ). Together, these results indicate that the cen-
tral region of Borealin interacts with the N-terminal basic
region of CHMP4C.
We then asked whether Borealin colocalized with CHMP4
proteins during cytokinesis in HeLa cells. We found that
all three GFP-tagged CHMP4 proteins accumulated at the
midbody in late cytokinesis (figure 4), in agreement with
published observations [9,10]. However, both GFP::CHMP4A
and GFP::CHMP4B were also found in the nucleus, whereas
GFP::CHMP4C was predominantly cytoplasmic (figure 4a,b).
Both GFP::CHMP4B and GFP::CHMP4C partially colocalized
with Borealin during late cytokinesis (figure 4b) but during
abscission only CHMP4 proteins were found at the midbody
(figure 4b), a localization pattern similar to that observed in
Drosophila cells (figure 1c). To analyse the localization of
CHMP4 proteins in more detail, we stained midbodiespurified from HeLa cells with antibodies directed against
CHMP4B and either tubulin or Borealin (figure 4c). These
experiments confirmed that CHMP4B accumulated at the
midbody and also showed that the ESCRT-III component
localized as discrete dots around the Flemming body to
form a structure resembling a pearl necklace (figure 4c).
Some of the CHMP4B dots appeared to colocalize with Bor-
ealin (figure 4c, arrows). In conclusion, CPC and ESCRT-III
Snf7 components associate at the midbody before abscission
in both Drosophila and human cells.3.3. Aurora B phosphorylates three serine residues in
the C-terminal linker region of CHMP4C
One obvious implication of the interaction between Borealin
and CHMP4 proteins is that CPC could regulate ESCRT-III
activity through phosphorylation of one or more of its com-
ponents. To test this hypothesis, we investigated whether
Aurora B could phosphorylate recombinant GST::CHMP4
proteins in an in vitro kinase assay. We found that all three
GST::CHMP4 proteins were phosphorylated by Aurora B in
vitro, although GST::CHMP4C seemed the best target
(figure 5a). Therefore, we next focused on the identification
of the CHMP4C residues phosphorylated by Aurora B
using the same in vitro phosphorylation assay. Only the
acidic C-terminal half of CHMP4C was strongly phosphory-
lated by Aurora B (figure 5b), and an in silico prediction
analysis using the GPS 2.1 software [23] identified a
serine located at position 210 as the best candidate for phos-
phorylation by Aurora B (table 3). The introduction of a
serine (S) to alanine (A) mutation at this position (S210A)
significantly reduced, but did not completely abolish, the
level of Aurora B phosphorylation (figure 5c). To identify
the other Aurora B phosphorylation sites, we mutagenized
the majority of serines and threonines listed in table 3 to ala-
nine and analysed the effect of these mutations, either alone
or in combination with S210A, on Aurora B phosphorylation
(see electronic supplementary material, figure S2). The
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Figure 3. Borealin interacts with ESCRT-III CHMP4 proteins in vivo and in vitro. (a) HeLa cells were transfected with constructs expressing PtA::Borealin or PtA alone
and one of the plasmids expressing GFP-tagged CHMP4 proteins or GFP alone. After 48 h, cells were harvested, and protein extracts used in a PtA pull-down assay.
The extracts and pull downs were then analysed by Western blot to detect GFP (a-GFP) and PtA (a-PtA). The numbers on the left indicate the sizes (kDa) of the
molecular mass marker. (b) GST::Borealin (GST::Bor) was purified from bacteria and incubated with CHMP4A, CHMP4B or CHMP4C translated and radio-labelled in
vitro and then pulled down using glutathione beads. The Ponceau S staining of the protein loading is shown at the bottom. The numbers on the left indicate the
sizes (kDa) of the molecular mass marker. (c) The schematic in the upper part illustrates Borealin protein domains and the position of different fragments used in the
GST pull-down assay. GST::Borealin (GST::Bor) fragments were purified from bacteria and incubated with CHMP4C translated and radio-labelled in vitro, and then
pulled down using glutathione beads. The Ponceau S staining of the protein loading is shown at the bottom. The numbers on the left indicate the sizes (kDa) of the
molecular mass marker. (d ) The schematic in the upper part illustrates CHMP4C protein domains and the two fragments used in the GST pull-down assay.
GST::CHMP4C fragments were purified from bacteria and incubated with Borealin translated and radio-labelled in vitro and then pulled down using glutathione
beads. The Ponceau S staining of the protein loading is shown at the bottom. The numbers on the left indicate the sizes (kDa) of the molecular mass marker.
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introduction of the S214A and S215A mutations together
with S210A almost completely abolished Aurora B phos-
phorylation (figure 5c and see electronic supplementary
material, figure S2) indicating that these three residues are
the major Aurora B phosphorylation sites in the C-terminal
region of CHMP4C. Quite interestingly, these residues lie in
a ‘linker’ region between the last two alpha-helices that has
been shown to be important for the regulation of CHMP4
protein activity [24].
To analyse CHMP4C phosphorylation in vivo, we gener-
ated an antibody against a CHMP4C peptide encompassing
residues 206–220 and containing phosphorylated serines at
positions 210, 214 and 215 (TARRSRAASSQRAEEC). This
antibody detected a band of approximately 30 kD and a
band corresponding to GFP-tagged CHMP4C in Western
blots of synchronized HeLa cell extracts. Both signals were
absent in a twin blot that had been pre-incubated withl-phosphatase (see electronic supplementary material,
figure S3), indicating that our antibody specifically recognizes
a phosphorylated form of CHMP4C. We next used this anti-
body to analyse the profile of phosphorylated CHMP4C
during mitotic exit and after treatment with the Aurora B
inhibitor ZM447439 [25]. HeLa cells were transfected with
GFP::CHMP4C, synchronized in metaphase by thymidine/
nocodazole block and then released into medium containing
either ZM447439 or its solvent DMSO as control. In control
cells, phosphorylated CHMP4C was strongly reduced 3 h
after nocodazole release, immediately after cyclin B degra-
dation and concomitantly with a reduction in the level of
Borealin (figure 5d ). These results indicate that CHMP4C is
dephosphorylated during mitotic exit at a time when cells
have already completed furrowing and CPC is being
degraded. We rule out the possibility that this profile might
reflect overall degradation of CHMP4C because the signal
merge
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Figure 4. CHMP4 proteins colocalize with Borealin to the midbody in HeLa cells. (a) HeLa cells were transfected with constructs expressing GFP::CHMP4A or
GFP::CHMP4C for 48 h and then fixed and stained to detect tubulin (red in the merged panels), GFP (green in the merged panels) and DNA (blue in the merged
panels). The insets show 2 magnification of the midbody. Scale bars, 10 mm. The presence and thickness of microtubule bundles at the intercellular bridge were
used as criteria to stage cells during cytokinesis. (b) HeLa cells were transfected with constructs expressing GFP::CHMP4B or GFP::CHMP4C for 48 h and then fixed
and stained to detect Borealin (red in the merged panels), GFP (green in the merged panels) and DNA (blue in the merged panels). Midbody presence and DNA
condensation were used as criteria to stage cells during cytokinesis. The insets show magnification of the midbody region at 2.5 (GFP::CHMP4B) and 3
(GFP::CHMP4C). Scale bars, 10 mm. (c) Midbodies were purified from HeLa cells and then fixed and stained to detect CHMP4B (green in the merged panel) and
either tubulin or Borealin (red in the merged panel). The arrows mark the CHMP4B dots that colocalize with Borealin. Scale bars, 5 mm.
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relative to GFP::CHMP4C (detected with an anti-GFP
antibody) did not follow the same profile as the signal detected
by our phospho-specific antibody (figure 5d ). Unfortunately,
we could not analyse the expression of endogenousCHMP4C because an antibody we generated against the
non-phosphorylated CHMP4C peptide and other two com-
mercially available antibodies could detect only the over-
expressed protein and not the endogenous pool of CHMP4C.
(d)
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Figure 5. Aurora B phosphorylates CHMP4C in vitro and in vivo. (a) GST-tagged CHMP4 proteins, GST alone or the positive control MBP (myelin basic protein) were
incubated with (þ) or without (2) recombinant Aurora B in the presence of [g-32P] ATP. The reactions were then separated by SDS-PAGE, and gels stained with
Coomassie Blue, dried and exposed at 2808C. The Coomassie Blue staining of the protein loading is shown at the bottom. Note that Aurora B is auto-
phosphorylated and co-migrated with GST::CHMP4B. The numbers on the right indicate the sizes (kDa) of the molecular mass marker. (b) GST-tagged full-length
CHMP4C (FL), GST-tagged N-terminal CHMP4Ca12, GST-tagged C-terminal CHMP4Ca345, GST alone and the positive control MBP were incubated with (þ) or
without (2) recombinant Aurora B in the presence of [g-32P] ATP. Products of the reactions were then separated by SDS-PAGE and the gels stained with Coomassie
Blue, dried and exposed at 2808C. The Coomassie Blue staining of the protein loading is shown at the bottom. The numbers on the right indicate the sizes (kDa) of
the molecular mass marker. (c) GST-tagged wild-type CHMP4Ca345 (WT), the two GST:: CHMP4Ca345 variants containing S to A mutations at position 210 (S210A)
or at position 210, 214 and 215 (StripleA), GST alone and the positive control MBP were incubated with (þ) or without (2) recombinant Aurora B in the presence
of [g-32P] ATP. Products of the reactions were then separated by SDS-PAGE and the gels stained with Coomassie Blue, dried and exposed at 2808C. The Coomassie
Blue staining of the protein loading is shown at the bottom. The numbers on the right indicate the sizes (kDa) of the molecular mass marker. (d ) HeLa cells were
transfected with GFP::CHMP4C, synchronized in metaphase with thymidine/nocodazole block and then released into medium containing either ZM447439 or its
solvent DMSO as control. Proteins were extracted, separated by SDS-PAGE, transferred onto PVDF membranes and analysed by Western blot to detect the variant of
CHMP4C phosphorylated at serine 210, 214 and 215 ( phospho-CHMP4C), cyclin B, Borealin, GFP::CHMP4C and tubulin as loading control. The numbers indicate the
sizes (kDa) of the molecular mass marker.
Table 3. Summary of the results from in silico prediction of potential Aurora B phosphorylation sites in the C-terminal half of CHMP4C and their validation by
Aurora B in vitro phosphorylation assay.
position residue peptide GPS 2.1 score in vitro phosphorylation
136 T DDLMQEITEQQDIAQ 0.931 nd
146 S QDIAQEISEAFSQRV 1.621 no
150 S QEISEAFSQRVGFGD 0.414 no
181 T EELNKKMTNIRLPNV 2.793 no
190 S IRLPNVPSSSLPAQP 0.207 no
191 S RLPNVPSSSLPAQPN 0.483 no
192 S LPNVPSSSLPAQPNR 2.069 no
204 S PNRKPGMSSTARRSR 1.724 no
205 S NRKPGMSSTARRSRA 2.276 no
206 T RKPGMSSTARRSRAA 0.655 nd
210 S MSSTARRSRAASSQR 10.379 yes
214 S ARRSRAASSQRAEEE 2.448 yes
215 S RRSRAASSQRAEEED 2.655 yes
233 T KQLAAWAT 0.655 nd
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Figure 6. Over-expression of phospho-mimic and non-phosphorylatable CHMP4C mutants leads to cytokinesis failure. (a) HeLa cells were transfected with constructs
expressing wild-type GFP::CHMP4C (WT) or one of the GFP::CHMP4C variants containing S to A or S to E substitutions at position 210 (S210A and S210E) or at
position 210, 214 and 215 (StripleA and StripleE) for 48 h and then fixed and stained to detect tubulin (red in the merged panel), GFP (green in the merged panel)
and DNA (blue in the merged panel). The insets show 2 magnification of the midbody. Scale bars, 10 mm. (b) Examples of multinucleate cells obtained after
transfection with GFP::CHMP4C mutants. HeLa cells were transfected with constructs expressing one of the GFP::CHMP4C variants containing S to A substitutions at
position 210 (S210A) or at position 210, 214 and 215 (StripleA) or GFP alone as a control for 48 h and then fixed and stained to detect tubulin (red in the merged
panel), GFP (green in the merged panel) and DNA (blue in the merged panel). Note that the cells expressing the two GFP::CHMP4C mutants are multinucleated.
Scale bars, 10 mm. (c) Percentage of multinucleate cells after treatment for 48 h with the GFP::CHMP4C constructs shown in panel (a). At least 600 cells were
counted in each experiment, n ¼ 4. Bars indicate standard errors.
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Strikingly, the phospho-specific CHMP4C signal disappea-
red much more rapidly after the addition of the Aurora B
inhibitor, even though both cyclin B and Borealin persisted
(figure 5d). We therefore conclude that Aurora B phos-
phorylates CHMP4C in vivo and that the Aurora B target
sites are dephosphorylated in cells that have completed
furrow ingression.3.4. CHMP4C phospho-mimic and non-
phosphorylatable mutants accumulate normally at
the midbody but their over-expression cause
cytokinesis failure
To investigate whether Aurora B phosphorylation could affect
CHMP4C localization and/or function, we transfected HeLa
cells with GFP::CHMP4C mutants containing either phospho-
mimic (serine to glutamate; S to E) or non-phosphorylatable
(S to A) substitutions at position 210 alone or at positions 210,
214 and 215 (triple mutants). All the mutants accumulated atthe midbody with a pattern similar to the wild-type protein
(figure 6a). This suggests that the phosphorylation status of
CHMP4C does not affect its ability to accumulate at the mid-
body, with the caveat that phospho-mimic mutants might not
exactly reflect the localization and behaviour of the endogenous
pool of phosphorylated CHMP4C. We next asked if expression
of these GFP::CHMP4C mutants could affect cytokinesis.
Over-expression of GFP-tagged wild-type CHMP4C has
already been reported to cause cytokinesis failure [6] and we
found that transfection of all four GFP::CHMP4C phospho-
mutants caused an increase in the number of multi-nucleated
cells compared with control cells transfected with GFP
alone or cells transfected with wild-type GFP::CHMP4C
(figure 6b,c). That the presumptive phospho-mimic mutants
behaved like the non-phosphorylatable variant might indicate
either that the S to E substitutions cannot successfully mimic
Aurora B phosphorylation or that the CHMP4C phosphoryl-
ation–dephosphorylation cycle must be tightly regulated for
proper CHMP4C function. Taken together, our results indicate
that phosphorylation by Aurora B controls the function of
CHMP4C during late cytokinesis.
(a)
(b)
(c)
α4
α5
α4
α5
membrane
a1 a3 a1 a2 a3 a1 a2 a3
a4
a5
Borealin
Borealin
Borealin
Aurora B
phosphorylation
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a5 a4 a3
a1 a2
a5 a4 a3
a1 a2
a4 a3
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1 233
CHMP4C
a12 (basic)
Aurora B
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a1 a2 a4a3 a5
a345 (acidic)
no CPC at the midbody and CHMP4C in open state
late cytokinesis
CPC at the midbody keeps CHMP4C in closed state
abscission
a2
Figure 7. Model for Aurora B-mediated regulation of CHMP4C during cytokinesis. (a) Schematic of CHMP4C indicating the position of the Aurora B target sites.
(b) Interaction with Borealin and phosphorylation by Aurora B keep CHMP4C in its ‘closed’ state at the midbody before abscission. (c) When CPC is no longer at the
midbody, CHMP4C can convert into its ‘open’ state and form membrane-associated polymers that mediate abscission.
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4. Discussion
Our findings identify a novel, evolutionarily conserved inter-
action between CPC and ESCRT-III Snf7 components. In
both Drosophila and human cells, the CPC Borealin subunit
interacts directly with Shrb/CHMP4 proteins, and in
human cells Aurora B phosphorylates the C-terminal tail of
CHMP4C. The latter mechanism seems to have evolved
specifically for the human CHMP4C protein because the
three residues phosphorylated by Aurora B—S210, S214
and S215—are not present in the other two human paralo-
gues and Shrb (figure 2). Consistent with this, Aurora B
weakly phosphorylated CHMP4A, CHMP4B and Shrb in
vitro (figure 5, and data not shown). The lack of conservation
of phosphorylation sites between orthologues is not uncom-
mon; for example, the Polo-like kinase-1 phosphorylation
sites in PRC1, a protein required for bundling the central
spindle, are not conserved in its Drosophila orthologue
Fascetto [26,27]. Our results suggest that the CHMP4C phos-
phorylation status does not affect its ability to accumulate
at the midbody but it does impair its function duringcytokinesis (figure 6). Interestingly, the serines phosphory-
lated by Aurora B are located in a region linking the
C-terminal-most two alpha-helices of CHMP4C (figure 7).
This region has been found to be essential for regulating
the activity of many ESCRT-III proteins in various biological
processes, including viral budding and cytokinesis [8,24].
Current models propose that ESCRT-III proteins cycle
between a default auto-inhibitory or ‘closed’ status and an
‘open’, active form (figure 7) [24,28]. In the ‘closed’ status,
the basic and acidic halves of the ESCRT-III protein are
tightly associated, and the protein is soluble and does not
interact with other components of the ESCRT machinery
and the membrane. In the ‘open’ form, the two halves of
the ESCRT-III protein dissociate, and the protein forms poly-
mers that associate with the membrane and other ESCRT-III
components (figure 7) [24]. The C-terminal tail of ESCRT-III
proteins, including the last a-helix and the linker region,
has been proposed to play a key role in the transition from
the closed to the open status, possibly through its interaction
with other regulatory factors [24,28]. Our results suggest that
Aurora B phosphorylation could prevent the conversion of
rsob.royalsocietypublishing.org
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active status (figure 7), possibly by inhibiting the association
of CHMP4C with some other regulatory partner(s).
The interaction of Borealin with the N-terminal basic region
of CHMP4 components could simply serve to bring Aurora B
in close proximity of its CHMP4C target or could have itself
a regulatory function. The evidence that this interaction is con-
served in Drosophila (figure 1), where Shrb does not contain
the Aurora B phosphorylation sites identified in CHMP4C
(figure 2) and does not seem to be a target of this kinase
(data not shown), strongly supports this second hypothesis.
Thus, we would like to propose a model where CPC could pre-
clude the activation of CHMP4 components at the cleavage site
by two concurrent mechanisms: (i) the binding of Borealin to
CHMP4 proteins could directly interfere with their ability
to form polymers and associate with the membrane, and
(ii) Aurora B phosphorylation could prevent the interaction
of CHMP4C with regulatory factors necessary for its transition
from an auto-inhibited to an active state (figure 7). These two
mechanisms could inhibit the formation of CHMP4 arrays or
filaments that have been described at the abscission site in
human cells [10] and thus abscission could proceed only
when CPC is no longer present at the midbody (figure 7).
This model would explain how CPC could control abscission
at the end of cytokinesis to prevent cell separation in the pres-
ence of DNA at the cleavage site and the consequent formation
of aneuploid and/or polyploid cells [18,19].5. Material and methods
5.1. Cell culture, DNA transfection and siRNA treatments
The Dmel strain of S2 cells (Invitrogen) was grown in a serum-
free medium supplemented with antibiotics. Generation of
blasticidin-resistant stable cell lines was performed as described
[29] with the only exception that Fugene HD transfection
reagent (Roche) was used following the supplier’s instructions.
Human HeLa (Kyoto and S3) cells were maintained in Dulbec-
co’s modified Eagle medium (Invitrogen) supplemented with
10 per cent foetal calf serum and antibiotics. To synchronize
cells in metaphase, HeLa cells were arrested in S phase by the
addition of 2 mM thymidine (Sigma) for 18 h, washed twice
with phosphate-buffered solution (PBS) and released for 5 h
in a fresh complete medium. After release, cells were cultured
for a further 16 h in a fresh complete medium in the presence
of 50 ng ml21 nocodazole (Sigma) and then harvested by mito-
tic shake-off. Mitotic cells were washed three times with PBS
and resuspended in a fresh complete medium with or without
the addition of the Aurora B inhibitor ZM447439 (Tocris
Bioscience) at the final concentration of 2 mM.
5.2. Midbody purification
HeLa S3 cells were synchronized in metaphase as described
earlier, but after nocodazole treatment, they were released in
a fresh medium supplemented with 25 mM MG132 (Sigma).
After 2 h, cells were washed three times in PBS, released in a
normal medium and allowed to progress throughout mitosis.
After 1.5–2 h, when the vast majority of cells had completed
furrowing, cells were centrifuged at 200g for 3 min, washed
once with warm H2O and gently resuspended in a hypotonic
swelling solution containing 1 mM PIPES pH 7, 1 mMMgCl2, 5 mg ml
21 Taxol (Sigma) and a cocktail of protease
inhibitors (Roche). Cells were immediately centrifuged at
200g for 3 min, resuspended in a solution containing 1 mM
PIPES pH 7, 1 mM EGTA, 1 per cent NP40, 5 mg ml21 Taxol
and protease inhibitors (Roche), and vortexed vigorously.
After the addition of 0.3 volumes of cold 50 mM 2-(N-morpho-
lino) ethane sulphonic acid (MES) pH 6.3, cells were incubated
on ice for 20 min and then centrifuged at 250g for 10 min. The
supernatant was then transferred to a new tube and centri-
fuged at 740g for 20 min to pellet midbodies. The pellet was
resuspended in 50 mM MES pH 6.3, layered over a cushion
of 40 per cent glycerol (w/v) in 50 mM MES pH 6.3 and centri-
fuged at 2800g for 45 min. After a final wash in 50 mM MES pH
6.3, midbodies were plated on poly-lysine-coated coverslips
and processed for immunofluorescence as described in §5.6.
5.3. Molecular biology
Gateway technology (Invitrogen) was used in all cloning pro-
cedures as described [30]. The destination vectors used for
the expression in Drosophila cultured cells were described
[29–31]. The pDEST15 vector (Invitrogen) was used for bac-
terial expression of GST-tagged proteins. pDEST53 and
pDEST47 (Invitrogen) were used to express GFP-tagged pro-
teins in human cells. pNPE1 (a gift from G. Tzolovsky,
University of Cambridge, UK) was used to express PtA-
tagged Borealin in HeLa cells.
5.4. Affinity purification and in vivo pull-down assays
PtA purifications were performed essentially as described pre-
viously [29,31]. Approximately, 109 cells were harvested by
centrifugation and frozen in liquid nitrogen. The cell pellet
was then resuspended in 5 ml of extraction buffer (50 mM
HEPES pH 7.5, 100 mM KAc, 50 mM KCl, 2 mM MgCl2,
2 mM EGTA, 0.1% NP-40, 5 mM DTT, 5% glycerol and Roche
Complete Protease Inhibitors) and homogenized using a
high-performance disperser (Fisher). Homogenates were agi-
tated at 48C for 30 min and clarified by centrifugation at
6000 r.p.m. in a SS34 rotor. Dynabeads (200 ml; Invitrogen)
conjugated to rabbit IgG (MP Biochemicals) were added to
the supernatants and incubated for 4 h under continuous agita-
tion at 48C. Beads were then washed five times for 10 min in
10 ml of extraction buffer. Proteins were then eluted from
beads with 0.5 M NH4OH and 0.5 mM EDTA, concentrated,
and analysed by LC–MS/MS. The MS/MS fragmentation
data that we achieved were used to search the National
Center for Biotechnology Information and Flybase data-
bases using the MASCOT search engine (http://www.
matrixscience.com). Probability-based MASCOT scores were
used to evaluate identifications. Only matches with p , 0.05
for random occurrence were considered significant.
For PtA pull-down assays in HeLa cells, cells were collected
and processed as explained earlier. Eluates were then frac-
tioned on an 8–16 per cent SDS–PAGE, transferred onto a
polyvinylidene fluoride (PVDF) membrane and probed with
the antibodies indicated in figure.
5.5. In vitro binding assay
DNA fragments coding for Borr, Borealin and CHMP4C were
generated by PCR and cloned into pDEST15 (Invitrogen) to
express N-terminal GST-tagged polypeptides in Escherichia
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11coli. The GST-tagged products were then purified using Glu-
tathione Sepharose 4B according to the manufacturer’s
instruction (GE Healthcare). [35S] Methionine-labelled Borea-
lin, CHMP4A, CHMP4B, CHMP4C and Shrb fragments were
prepared from corresponding PCR products amplified using
primers harbouring a T7 promoter and then transcribed and
translated in vitro using the TnT T7 quick-coupled transcrip-
tion/translation system (Promega) in the presence of [35S]
methionine (Perkin Elmer). Generally, 25 ml of glutathione
sepharose beads containing purified GST-proteins were
mixed with 10 ml of [35S] methionine-labelled polypeptides
and 300 ml of NET-N þ buffer (50 mM Tris–HCl, pH 7.4,
150 mM NaCl, 5 mM EDTA, 0.5% NP-40 and a cocktail of
Roche complete protease inhibitors) and incubated in ice
for 30 min with periodic agitation. The mixture was then
washed five times by adding 500 ml of NET-Nþ buffer fol-
lowed by centrifugation at 500g for 1 min. Beads were
resuspended in 25 ml of Laemmli SDS-PAGE sample buffer
and typically one-fifth of the mixture (10 ml) was loaded on
8–16 per cent Tris–Glycine gel. Proteins were then transferred
onto a nitrocellulose membrane using the iBlot dry blotting
system (Invitrogen) and exposed to X-ray films at 2808C.
5.6. Antibodies and microscopy
Antibodies were raised in rabbits against a synthetic CHMP4C
peptide encompassing residues 206–220 and containing
phosphorylated serines at position S210, S214 and S215
(TARRSRAASSQRAEEC). Peptide synthesis, conjugation,
rabbit immunizations, serum production and affinity purifi-
cation were carried out by Abgent (Generon, UK). Other
antibodies used in this study are rabbit anti-CHMP4B (a kind
gift of A. Sagona and H. Stenmark [32]) mouse monoclonal
anti-tubulin (clone DM1A, Sigma), rabbit anti-Aurora B
(Drosophila; [33]) mouse monoclonal anti-Borealin, mouse
monoclonal anti-GFP (Roche), peroxidase-chrompure
anti-rabbit IgG (Jackson Laboratories). Peroxidase and Alexa-
fluor-conjugated secondary antibodies were purchased from
Jackson Laboratories and Invitrogen.
For immunofluorescence, Dmel and HeLa cells were grown
on 22  22 mm coverslips (Menzel-Gläser) and fixed in PHEM
buffer (60 mM Pipes, 25 mM Hepes pH 7, 10 mM EGTA, 4 mM
MgCl2, 3.7% formaldehyde) for 12 min. They were then
washed three times for 10 min with PBS and incubated in
blocking buffer (PBS, 0.5% Triton X-100, 3–5% BSA) for 1 h
at room temperature. Incubation with primary antibodies
was performed over night at 48C in PBT (PBS, 0.1% Triton X-
100, 1% BSA). After two washes in PBT, coverslips were incu-
bated with Alexa-fluor-conjugated secondary antibodies
(Invitrogen) diluted in PBT for 2 h at room temperature andthen washed twice with PBT and once with PBS. Coverslips
were finally mounted using Vectashield mounting medium
with DAPI (40,6-diamidino-2-phenylindole; Vector Labora-
tories) and visualized on a Zeiss Axiovert 200 fluorescence
microscope equipped with a 100 objective (NA 1.4). Images
were acquired using a Photometrics CoolSNAP HQ2 camera
with METAMORPH software (Molecular Devices) and assembled
and adjusted for contrast using ADOBE PHOTOSHOP CS3.
5.7. In vitro phosphorylation assay
Purified GST-tagged CHMP4A, CHMP4B and CHMP4C pro-
teins, including CHMP4Ca12, CHMP4Ca345 and various
CHMP4Ca345 variants containing S to A mutations, were
incubated with or without 100 ng recombinant Aurora B
(Cell Signaling) in a kinase buffer (20 mM Hepes pH 7.5,
5 mM MgCl2, 1 mM DTT, 0.1 mM ATP) containing 2 mCi
[g-32P]ATP (Perkin Elmer). Reactions were incubated at 308C
for 30 min, quenched by the addition of 2 Laemmli sample
buffer, boiled and separated by electrophoresis on a 4–20 per
cent SDS-PAGE. Gels were stained with Bio-Safe Coomassie
stain (Bio-Rad), and then dried and exposed at 2808C.
5.8. Phosphatase treatment
Proteins were separated by SDS-PAGE and transferred to
PVDF Immobilon-P membrane (Millipore). The blots were
then washed twice with water, blocked in Tris-buffered
saline (TBS) containing 0.1 per cent BSA and 0.1 per cent
Triton X-100 for 1 h at room temperature and then incubated
in phosphatase buffer (TBS 1X, 0.1% BSA, 0.1% Triton X-100,
2 mM MnCl2) containing 400 units ml
21 of l-phosphatase
(NEB) for 4 h at room temperature. After incubation, blots
were washed for 5 min in PBS þ 0.1 per cent Tween 20 and
processed for antibody detection.6. Acknowlegements
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